Great point! With the density test data, just lik
Post# of 148177
So that means it is very likely they will need 700mg safety data for Combo. Which might change some questions slightly.
Combo/BLA
When will the 700mg safety data be complete?
Have you determined the dose vs Receptor Occupancy?
What is needed from the FDA before the BLA CMC part can be submitted?
Any response from FDA to our first part of the BLA?
Did the early discontinues in the placebo arm happen before steady-state? (pvalue for completed between groups <.02)